Clinical trial
A Phase II Study of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma
NCT04065776 is registered in ClinicalTrials.gov with St. Jude Children's Research Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Study of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma
- Lead sponsor
- St. Jude Children's Research Hospital
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- August 28, 2019
- Completion date
- July 31, 2028
- Enrollment
- 48 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
diffuse astrocytoma, ganglioglioma, glioma, optic pathway glioma, pilocytic astrocytoma, pilomyxoid astrocytoma, pleomorphic xanthoastrocytoma